1. Home
  2. UTHR vs AER Comparison

UTHR vs AER Comparison

Compare UTHR & AER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • AER
  • Stock Information
  • Founded
  • UTHR 1996
  • AER 1995
  • Country
  • UTHR United States
  • AER Ireland
  • Employees
  • UTHR N/A
  • AER N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • AER Diversified Commercial Services
  • Sector
  • UTHR Health Care
  • AER Consumer Discretionary
  • Exchange
  • UTHR Nasdaq
  • AER Nasdaq
  • Market Cap
  • UTHR 16.1B
  • AER 18.0B
  • IPO Year
  • UTHR 1999
  • AER 2006
  • Fundamental
  • Price
  • UTHR $367.97
  • AER $95.52
  • Analyst Decision
  • UTHR Buy
  • AER Strong Buy
  • Analyst Count
  • UTHR 14
  • AER 10
  • Target Price
  • UTHR $378.36
  • AER $110.50
  • AVG Volume (30 Days)
  • UTHR 280.3K
  • AER 822.9K
  • Earning Date
  • UTHR 02-19-2025
  • AER 02-26-2025
  • Dividend Yield
  • UTHR N/A
  • AER 1.05%
  • EPS Growth
  • UTHR 25.10
  • AER 19.27
  • EPS
  • UTHR 22.72
  • AER 12.74
  • Revenue
  • UTHR $2,756,200,000.00
  • AER $7,817,256,000.00
  • Revenue This Year
  • UTHR $26.19
  • AER $5.05
  • Revenue Next Year
  • UTHR $10.79
  • AER $2.45
  • P/E Ratio
  • UTHR $16.19
  • AER $7.51
  • Revenue Growth
  • UTHR 25.04
  • AER 4.50
  • 52 Week Low
  • UTHR $208.62
  • AER $75.25
  • 52 Week High
  • UTHR $417.82
  • AER $100.81
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 53.51
  • AER 49.33
  • Support Level
  • UTHR $357.25
  • AER $93.04
  • Resistance Level
  • UTHR $372.34
  • AER $97.69
  • Average True Range (ATR)
  • UTHR 8.70
  • AER 1.76
  • MACD
  • UTHR 0.91
  • AER 0.09
  • Stochastic Oscillator
  • UTHR 79.59
  • AER 53.33

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

About AER AerCap Holdings N.V.

AerCap Holdings NV is an aircraft leasing company. Its major activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties. Through its subsidiary, the group also provides engine leasing, certified aircraft engines, airframes, and engine parts. Its geographical segments include China, United States, and Other countries.

Share on Social Networks: